|Three Months Ended December 31,||Twelve Months Ended December 31,|
|U.S. Spine & Other||47,725||45,594||4.7%||190,546||174,479||9.2%|
|Impact of changes in currency exchange rates||$626||$—||$6,798||$—|
|Total revenues excluding the effects of currency exchange rates||$215,058||$203,523||5.7%||$837,669||$780,078||7.4%|
* The Company revised revenues in the U.S. Extremities and International segments in the fourth quarter and full year of 2011. This revision moves $1.0 million of international revenues resulting from the Ascension acquisition from the U.S. Extremities segment to the International segment during those periods.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts